#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain stem glioma Breast cancer metastatic Endocrine ophthalmopathy Infantile apnoea Juvenile psoriatic arthritis Extranodal marginal zone B-cell lymphoma (MALT type) Hodgkin's disease recurrent Round cell liposarcoma Systemic mastocytosis Interstitial lung disease Polyneuropathy Waldenstrom's macroglobulinaemia recurrent Blood iron increased Factor VIII deficiency ROHHAD syndrome More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors Uterine leiomyosarcoma – Treatment Methylmalonic acidaemia – Trials in Disease Progressive multifocal leukoencephalopathy – Trials in Disease Retinoblastoma – Life with Disease Ewing’s sarcoma – Basic Information Glomerulonephritis membranoproliferative Cerebral arteriovenous malformation haemorrhagic – Life with Disease Factor IX deficiency – Trials in Disease Lymphangioma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tasimelteon Air, Medicinal Inclisiran Sodium Cobimetinib Sonidegib TETANUS TOXOID Dabigatran Etavopivat Linvoseltamab IMB 101 Nebivolol Medi0618 Dazostinag BLEXIMENIB Botaretigene Sparoparvovec Lolium Perenne Gadobutrol WEF-001 Rtp-026 Sodium Cenobamate More therapies…

    Learn about Your Condition

    Endometrial cancer stage II Endocrine ophthalmopathy Pharyngeal cancer stage I Coronary artery dissection Tympanic membrane hyperaemia Alveolar proteinosis Nephrolithiasis Necrotising myositis Lung cancer metastatic Perinatal depression Clinically isolated syndrome Biliary neoplasm Mucopolysaccharidosis III Becker's muscular dystrophy Cardiovascular disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Minocycline and Celecoxib for Patients with Major Depressive Disorder Not Responding to Antidepressants

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Minocycline
    • Celecoxib
    Belgium

  • Study on the Effects and Safety of Nicotinamide for Patients with Type 2 Diabetes and Liver Fibrosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Nicotinamide
    Spain

  • Study on Fremanezumab for Pain Relief in Patients with Complex Regional Pain Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Complex regional pain syndrome
    Investigated Drugs:
    • Fremanezumab
    Denmark

  • Study on Hydrochlorothiazide and Tolvaptan for Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Tolvaptan
    • Hydrochlorothiazide
    Austria Belgium France Germany The Netherlands Spain

  • Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

    Recruiting

    3 1
    Investigated Drugs:
    • Abelacimab
    Bulgaria Croatia Czechia Estonia Finland Germany +9

  • Study on the Effect of Cholestyramine on Pollutant Levels in Obese Women Eligible for Bariatric Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • Colestyramine
    France
Previous Page
1 … 588 589 590 591 592 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!